ClinVar Miner

Submissions for variant NM_000059.4(BRCA2):c.9400G>A (p.Gly3134Ser)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV004952501 SCV005551985 uncertain significance Hereditary cancer-predisposing syndrome 2024-11-19 criteria provided, single submitter clinical testing The p.G3134S variant (also known as c.9400G>A), located in coding exon 24 of the BRCA2 gene, results from a G to A substitution at nucleotide position 9400. The glycine at codon 3134 is replaced by serine, an amino acid with similar properties. In one study, this variant was reported in 0/60,466 breast cancer cases and in 1/53,461 controls (Dorling et al. N Engl J Med 2021 02;384:428-439). This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.